Cite
Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally.
MLA
Maldonado-Puebla, Martin, et al. “Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally.” The Journal of Allergy and Clinical Immunology. In Practice, vol. 12, no. 2, Feb. 2024, pp. 272–80. EBSCOhost, https://doi.org/10.1016/j.jaip.2023.11.005.
APA
Maldonado-Puebla, M., Akenroye, A., Busby, J., Cardet, J. C., & Louisias, M. (2024). Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally. The Journal of Allergy and Clinical Immunology. In Practice, 12(2), 272–280. https://doi.org/10.1016/j.jaip.2023.11.005
Chicago
Maldonado-Puebla, Martin, Ayobami Akenroye, John Busby, Juan Carlos Cardet, and Margee Louisias. 2024. “Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally.” The Journal of Allergy and Clinical Immunology. In Practice 12 (2): 272–80. doi:10.1016/j.jaip.2023.11.005.